CoChat

Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls

Open access
Nathanson, David, Svensson, Ann-Marie, Miftaraj, Mervete, Franzén, Stefan, Bolinder, Jan, Eeg-Olofsson, Katarina · 2021 · Diabetologia

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Aims/hypothesis: The aim of this work was to evaluate changes in glycaemic control (HbA 1c ) and rates of severe hypoglycaemia over a 2 year period after initiation of flash glucose monitoring (FM) in type 1 diabetes. Methods: Using data from the Swedish National Diabetes Registry, 14,372 adults with type 1 diabetes with a new registration of FM during 2016–2017 and with continued FM for two consecutive years thereafter, and 7691 control individuals using conventional self-monitoring of blood glucose (SMBG) during the same observation period, were included in a cohort study. Propensity sores and inverse probability of treatment weighting (IPTW) were used to balance FM users with SMBG users. Changes in HbA 1c and events of severe hypoglycaemia were compared. Results: After the start of FM, the difference in IPTW change in HbA 1c was slightly greater in FM users compared with the control group during the follow-up period, with an estimated mean absolute difference of −1.2 mmol/mol (−0.11%) (95% CI −1.64 [−0.15], −0.75 [−0.07]; p < 0.0001) after 15–24 months. The change in HbA 1c was greatest in those with baseline HbA 1c ≥70 mmol/mol (8.5%), with the estimated mean absolute difference being −2.5 mmol/mol (−0.23%) (95% CI −3.84 [−0.35], −1.18 [−0.11]; p = 0.0002) 15–24 months post index. The change was also significant in the subgroups with initial HbA 1c ≤52 mmol/mol (6.9%) and 53–69 mmol/mol (7.0–8.5%). Risk of severe hypoglycaemic episodes was reduced by 21% for FM users compared with control individuals using SMBG (OR 0.79 [95% CI 0.69, 0.91]; p = 0.0014)]. Conclusions/interpretation: In this large cohort, the use of FM was associated with a small and sustained improvement in HbA 1c , most evident in those with higher baseline HbA 1c levels. In addition, FM users experienced lower rates of severe hypoglycaemic events compared with control individuals using SMBG for self-management of glucose control. Graphical abstract:

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-021-05437-z

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow chart for selection process of the study population
Fig. 1 Flow chart for selection process of the study populationCC BY · PubMed Central
Fig. 2 Weighted (IPTW) change in HbA1c and 95% CIs for FM users and control individuals during the observational period from index up to 20 months after index. n=the total number of observations contributing at each time point
Fig. 2 Weighted (IPTW) change in HbA1c and 95% CIs for FM users and control individuals during the observational period from index up to 20 months after index. n=the total number of observations contributing at each time pointCC BY · PubMed Central
Fig. 3 General updated mean HbA1c for FM users (a) and for control individuals (b), categorised into low (≤52 mmol/mol), intermediate (53–69 mmol/mol) and high (≥70 mmol/mol) HbA1c levels. The graphs show unadjusted data, therefore a comparison between the groups based on the figure should be made cautiously as data are not adjusted for confounders. The shaded area depicts indicative 95% CIs for the smooth functions of HbA1c. Note that the 95% CI does not account for multiple repeated measures from the same individual. The spikes in the graph depicting general updated mean for HbA1c observed pre-index in the group with HbA1c ≥70 mmol/mol and the pre-index dips in the group with HbA1c ≤52 mmol/mol are caused by the effect of the ‘regression to the mean’ and are accordingly not associated with an effect of an intervention or selection bias
Fig. 3 General updated mean HbA1c for FM users (a) and for control individuals (b), categorised into low (≤52 mmol/mol), intermediate (53–69 mmol/mol) and high (≥70 mmol/mol) HbA1c levels. The graphs show unadjusted data, therefore a comparison between the groups based on the figure should be made cautiously as data are not adjusted for confounders. The shaded area depicts indicative 95% CIs for the smooth functions of HbA1c. Note that the 95% CI does not account for multiple repeated measures from the same individual. The spikes in the graph depicting general updated mean for HbA1c observed pre-index in the group with HbA1c ≥70 mmol/mol and the pre-index dips in the group with HbA1c ≤52 mmol/mol are caused by the effect of the ‘regression to the mean’ and are accordingly not associated with an effect of an intervention or selection biasCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 61

Metadata

Authors
Nathanson, D., Svensson, A.-M., Miftaraj, M., Franzén, S., Bolinder, J., & Eeg-Olofsson, K.
Affiliations
  • Karolinska University Hospital (SE)
  • Centre of Registers Vastra Gotaland (SE)
Corresponding author
Bolinder, Jan
Venue
Diabetologia
Published
2021-03-27
Volume
64
Issue
7
Pages
1595-1603
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W3146911802
Cited by
61
References
30
Citations by year
2026: 8 · 2025: 7 · 2024: 14 · 2023: 13 · 2022: 13 · 2021: 6
FWCI
8.59
Type
journal article
Language
en
Open access
Licence
Locations
  • Diabetologia (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • the Swedish state under the agreement between the Swedish government and the county councils, the ALF agreement (ALFGBG-698991)
  • Swedish Diabetes Association and the Strategic Research Program on Diabetes at Karolinska Institutet
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
flash glucose monitoring, type 1 diabetes, glycemic control, HbA1c, severe hypoglycemia, self-monitoring of blood glucose, continuous glucose monitoring, diabetes management, adults with type 1 diabetes, propensity score matching, inverse probability of treatment weighting
MeSH terms
Glycemic Control, Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glycated Hemoglobin, Humans, Hypoglycemia, Injections, Insulin, Insulin Infusion Systems, Longitudinal Studies, Male, Middle Aged, Retrospective Studies, Sweden, Blood Glucose Self-Monitoring, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls. https://app.cochat.ai/papers/10.1007/s00125-021-05437-z
The paper
Nathanson, D., Svensson, A.-M., Miftaraj, M., Franzén, S., Bolinder, J., & Eeg-Olofsson, K. (2021). Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls. Diabetologia. https://doi.org/10.1007/s00125-021-05437-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.